Financial Risk of the Biotech Industry versus the Pharmaceutical Industry

ISSN： 1175-5652

Source： Applied Health Economics and Health Policy, Vol.7, Iss.3, 2009-09, pp. : 155-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The importance of the pharmaceutical industry to the UK economy

By Earl-Slater Alan

Journal of Management in Medicine, Vol. 12, Iss. 1, 1998-01 ,pp. : 5-20

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Technology versus products – what’s the real driving force of interest for the pharmaceutical industry?

By Reiland Thomas L

Expert Opinion on Drug Delivery, Vol. 1, Iss. 1, 2004-11 ,pp. : 1-2

Informa Healthcare

Access to resources Recommend Favorite

Quality management benchmarking: FDA compliance in pharmaceutical industry

By Jochem Roland Landgraf Katja

International Journal of Health Care Quality Assurance, Vol. 23, Iss. 8, 2010-10 ,pp. : 690-698

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Inhalable Dust Measurements as a First Approach to Assessing Occupational Exposure in the Pharmaceutical Industry

By Champmartin C. Clerc F.

Journal of Occupational and Environmental Hygiene, Vol. 11, Iss. 2, 2014-02 ,pp. : 85-92

Taylor & Francis Ltd

Access to resources Recommend Favorite

A critique of emerging European legislation in the pharmaceutical industry: a clinical trials analysis

By Murray Elizabeth McAdam Rodney Burke Moira T

International Journal of Health Care Quality Assurance, Vol. 17, Iss. 7, 2004-07 ,pp. : 389-393

Emerald Group Publishing Ltd

Access to resources Recommend Favorite